All Stories

  1. A bitter pill to swallow: adjustments to oral contraceptive pill use in polycystic ovary syndrome
  2. The great debate: Surgical outcomes of laparoscopic versus laparotomic myomectomy. A meta-analysis to critically evaluate current evidence and look over the horizon
  3. Editorial: Early cervical cancer: laparotomic vs minimally invasive surgery and fertility-sparing possible strategies
  4. Approaches to prevention of gynecological malignancies
  5. Reproductive Outcomes in Young Women with Early-Stage Cervical Cancer Greater than 2 cm Undergoing Fertility-Sparing Treatment: A Systematic Review
  6. Effect of Maternal Age and Body Mass Index on Induction of Labor Using Oral Misoprostol in Late-Term Pregnancies: A Retrospective Cross-Sectional Study
  7. Sentinel node mapping in high-intermediate and high-risk endometrial cancer: Analysis of 5-year oncologic outcomes
  8. Deciphering the “David Sign”: Intersections in esthetic surgery and renaissance sculpture
  9. Health-related quality of life after hysterectomy for endometrial cancer: the impact of enhanced recovery after surgery (ERAS) shifting paradigm
  10. Placentation and complications of ART pregnancy. An update on the different possible etiopathogenic mechanisms involved in the development of obstetric complications
  11. Safety and efficacy of a class II medical device based on highly purified and standardized plant extracts in the management of post-menopausal patients with vulvar and vaginal atrophy: a single-center prospective observational study
  12. Polycystic Ovary Syndrome and Alteration of Vocal Function: A Systematic Review and Meta-Analysis
  13. Editorial: Minimally invasive surgery in gynecology oncology: current trends and controversies
  14. Hormone replacement therapy in gynecological cancer survivors and BRCA mutation carriers: a MITO group survey
  15. Sentinel node mapping in endometrial cancer
  16. Targeting BRAF pathway in low-grade serous ovarian cancer
  17. Pharmacotherapy for the treatment of recurrent cervical cancer: an update of the literature
  18. Spotlight on Compounded Bioidentical Hormones
  19. Robotic vs. laparoscopic approach in obese patients with endometrial cancer: which is the best? A mini-review
  20. HPV-related lesions after hysterectomy for high-grade cervical intraepithelial neoplasia and early-stage cervical cancer: A focus on the potential role of vaccination
  21. Pathogenesis and Treatments of Endometrial Carcinoma
  22. Patterns of recurrence in FIGO stage IB1-IB2 cervical cancer: Comparison between minimally invasive and abdominal radical hysterectomy
  23. Laparoscopic Prediction of Primary Cytoreducibility of Epithelial Ovarian Cancer
  24. Management of Endometrial Cancer: Molecular Identikit and Tailored Therapeutic Approach
  25. HPV persistence after cervical surgical excision of high‐grade cervical lesions
  26. Prevention, Screening, Treatment and Follow-Up of Gynecological Cancers: State of Art and Future Perspectives
  27. Uterine sarcomas: A critical review of the literature
  28. The role of L1CAM as predictor of poor prognosis in stage I endometrial cancer: a systematic review and meta-analysis
  29. Therapeutic Approaches to Vulvar Cancer: A Review of Literature
  30. Androgens and Female Sexuality: Molecular Insights, Neuroendocrine Crosstalk and Future Therapeutic Directions
  31. Duration of human papillomavirus persistence and its relationship with recurrent cervical dysplasia
  32. Ten-year outcomes following laparoscopic and open abdominal radical hysterectomy for “low-risk” early-stage cervical cancer: A propensity-score based analysis
  33. PARP Inhibitors in Newly Diagnosed and Recurrent Ovarian Cancer
  34. Vulvodynia: A practical guide in treatment strategies
  35. Magnetic resonance imaging-radiomics in endometrial cancer: a systematic review and meta-analysis
  36. Sexual dysfunctions in breast cancer patients: evidence in context
  37. Outcomes of High-Grade Cervical Dysplasia with Positive Margins and HPV Persistence after Cervical Conization
  38. Recent Advances in Endometrial Cancer Management
  39. Novel Insights into Molecular Mechanisms of Endometrial Diseases
  40. Role of Genomic and Molecular Biology in the Modulation of the Treatment of Endometrial Cancer: Narrative Review and Perspectives
  41. Laparoscopic Versus Abdominal Radical Hysterectomy
  42. Learning Laparoscopic Radical Hysterectomy: Are We Facing an Emerging Situation?
  43. Effect of maternal age and body mass index on induction of labor with oral misoprostol for premature rupture of membrane at term: A retrospective cross-sectional study
  44. Obstructed Hemivagina and Ipsilateral Renal Anomaly Syndrome: A Systematic Review about Diagnosis and Surgical Management
  45. Use of botulinum toxin in aesthetic medicine and gynaecology: current approaches, controversies, and future directions
  46. Hysterectomy Using Vaginal Natural Orifice Transluminal Endoscopic Surgery Compared with Classic Laparoscopic Hysterectomy: A New Advantageous Approach? A Systematic Review on Surgical Outcomes
  47. Radiomics and Molecular Classification in Endometrial Cancer (The ROME Study): A Step Forward to a Simplified Precision Medicine
  48. Laparoscopic management of rudimentary uterine horns in patients with unicornuate uterus: a systematic review
  49. Recent Research on the Treatment of Vulvar and Vaginal Atrophy
  50. Hysterectomy: Let’s Step Up the Ladder of Evidence to Look Over the Horizon
  51. Personalized Treatment of Vulvar Cancer
  52. Evaluation of Surgical Outcomes of Abdominal Radical Hysterectomy and Total Laparoscopic Radical Hysterectomy for Cervical Cancer: A Retrospective Analysis of Data Collected before the LACC Trial
  53. Fractional Co2 laser for vulvo-vaginal atrophy in gynecologic cancer patients: A valid therapeutic choice? A systematic review
  54. Radical Hysterectomy for Early Stage Cervical Cancer
  55. The Efficacy of Fractional CO2 Laser in the Treatment of Genitourinary Syndrome of Menopause: A Large Prospective Observational Study
  56. Practice patterns and 90-day treatment-related morbidity in early-stage cervical cancer
  57. Advances on Prevention and Screening of Gynecologic Tumors: Are We Stepping Forward?
  58. Percutaneous-assisted laparoscopy for ovarian tissue cryopreservation: a single-center experience
  59. New Advances in Cervical Cancer: From Bench to Bedside
  60. Minimally Invasive Surgery for Cervical Cancer: Should We Look beyond Squamous Cell Carcinoma?
  61. Loop Electrosurgical Excision Procedure and Cold Knife Conization: which is the best? A large retrospective study
  62. The role of preoperative frailty assessment in patients affected by gynecological cancer: a narrative review
  63. Development of a Nomogram Predicting the Risk of Persistence/Recurrence of Cervical Dysplasia
  64. Predictors of Pain Development after Laparoscopic Adnexectomy: A Still Open Challenge
  65. HAPPY MAMA Project (Part 2)—Maternal Distress and Self-Efficacy: A Pilot Randomized Controlled Field Trial
  66. Molecular markers and endometrial cancer
  67. Age-Adjusted Charlson Comorbidity Index Predicts Survival in Endometrial Cancer Patients
  68. The giant steps in surgical downsizing toward a personalized treatment of vulvar cancer
  69. Prognostic Role of the Removed Vaginal Cuff and Its Correlation with L1CAM in Low-Risk Endometrial Adenocarcinoma
  70. Preoperative frailty assessment in patients undergoing gynecologic oncology surgery: A systematic review
  71. Reducing the radicality of surgery for vulvar cancer: are smaller margins safer?
  72. Relationship between cervical excisional treatment for cervical intraepithelial neoplasia and obstetrical outcome
  73. Update on surgical treatment of female stress urinary incontinence
  74. Modified fragility index and surgical complexity score are able to predict postoperative morbidity and mortality after cytoreductive surgery for advanced ovarian cancer
  75. Urinary incontinence in women: state of the art and medical treatment
  76. High-risk HPV-positive and -negative high-grade cervical dysplasia: Analysis of 5-year outcomes
  77. The role of the sentinel lymph node in vulvar cancer
  78. Assessing the Long-Term Role of Vaccination against HPV after Loop Electrosurgical Excision Procedure (LEEP): A Propensity-Score Matched Comparison
  79. Recurrence rate after loop electrosurgical excision procedure (LEEP) and laser Conization: A 5-year follow-up study
  80. The V‐Y gluteal fold advancement flap: Outcomes following radical surgery for vulvar malignancies
  81. Hepatobiliary Disease Resection in Patients with Advanced Epithelial Ovarian Cancer: Prognostic Role and Optimal Cytoreduction
  82. Safety evaluation of fractional CO2 laser treatment in post-menopausal women with vaginal atrophy: A prospective observational study
  83. New medical device containing verbascoside, carrageenan and glycerophosphoinositol for the treatment of dyspareunia in reproductive age women: A prospective observational study
  84. Myasthaenia gravis in pregnancy, delivery and newborn
  85. Lymphadenectomy in Ovarian Cancer: Is It Still Justified?
  86. Does hysterosalpingo-foam sonography have any therapeutic effect? A systematic review
  87. The use of misoprostol and mifepristone in second trimester interruption of pregnancy: State of art
  88. Predictors of postoperative overall and severe complications after surgical treatment for endometrial cancer: The role of the fragility index
  89. Complementemia in pregnancies with antiphospholipid syndrome
  90. Incidence of Neonatal Neutropenia, Leukopenia, and Anemia After In Utero Exposure to Chemotherapy For Maternal Cancer
  91. Lupus anticoagulant remission after gluten-free diet in a coeliac pregnant woman
  92. Vaginal Native Tissue Repair for Posterior Compartment Prolapse: Long-term Analysis of Sexual Function and Quality of Life in 151 Patients
  93. Vaginal Native Tissue Repair for Posterior Compartment Prolapse: Long-Term Analysis of Sexual Function and Quality of Life in 151 Patients
  94. Usefulness of Ospemifene in the treatment of urgency in menopausal patients affected by mixed urinary incontinence underwent mid-urethral slings surgery
  95. Antiphospholipid syndrome: An update on risk factors for pregnancy outcome
  96. Therapeutic vaccines and immune checkpoints inhibition options for gynecological cancers
  97. Overactive bladder syndrome treatment with ospemifene in menopausal patients with vulvovaginal atrophy: improvement of sexuality?
  98. Orally Administered Combination of Hyaluronic Acid, Chondroitin Sulfate, Curcumin, and Quercetin in the Prevention of Postcoital Recurrent Urinary Tract Infections: Analysis of 98 Women in Reproductive Age After 6 Months of Treatment
  99. Vulvo-vaginal reconstruction after radical excision for treatment of vulvar cancer: Evaluation of feasibility and morbidity of different surgical techniques
  100. A medical device containing purified bovine colostrum (Monurelle Biogel) in the treatment of vulvovaginal atrophy in postmenopausal women: Retrospective analysis of urinary symptoms, sexual function, and quality of life
  101. Retrospective analysis in 46 women with vulvovaginal atrophy treated with ospemifene for 12 weeks: improvement in overactive bladder symptoms
  102. Bevacizumab in Ovarian Cancer: State of the Art and Unanswered Questions
  103. Prognostic role of inguinal lymphadenectomy in vulvar squamous carcinoma: younger and older patients should be equally treated. A prospective study and literature review